Member access

4-Traders Homepage  >  Shares  >  Nyse MKT  >  ImmunoCellular Therapeutics Ltd    IMUC   US4525361055

 SummaryQuotesChartsNewsCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Delayed Quote. Delayed Nyse Mkt
05/18/2015 05/19/2015 05/20/2015 05/21/2015 05/22/2015 Date
0.4622(c) 0.4526(c) 0.51(c) 0.485(c) 0.47(c) Last
405 507 332 904 1 802 898 666 785 317 060 Volume
-3.20% -2.08% +12.68% -4.90% -3.09% Change
More quotes
Financials ($)
Sales 2015 -
EBIT 2015 -15,7 M
Net income 2015 -14,9 M
Debt 2015 -
Yield 2015 -
Sales 2016 -
EBIT 2016 -21,5 M
Net income 2016 -21,6 M
Debt 2016 -
Yield 2016 -
PER 2015 -
PER 2016
Capi. / Sales 2015 0
Capi. / Sales 2016 0
Capitalization 42,4 M
More Financials
Company
ImmunoCellular Therapeutics Ltd. is a clinical-stage biotechnology company that is developing immune-based therapies for the treatment of cancers.Immunotherapy is an emerging approach to treating cancer in which a patients own immune system is stimulated to target tumor antigens, which are... 
More about the company
Latest news on IMMUNOCELLULAR THERAPEUTIC
05/20 IMMUNOCELLULAR THERAPEUTICS : Announces First Quarter 2015 Financial Results
05/19 IMMUNOCELLULAR THERAPEUTICS : Entry into a Material Definitive Agreement (form 8..
05/19 IMMUNOCELLULAR THERAPEUTICS : to Present at Marcum MicroCap Conference on May 28..
05/14 IMMUNOCELLULAR THERAPEUTICS : Reports First Quarter 2015 Financial Results
05/11 IMMUNOCELLULAR THERAPEUTICS : Management's Discussion and Analysis of Financial ..
05/11 IMMUNOCELLULAR THERAPEUTICS : Results of Operations and Financial Condition, Fin..
05/11 IMMUNOCELLULAR THERAPEUTICS : Announces First Quarter 2015 Financial Results
05/11 IMMUNOCELLULAR THERAPEUTICS : Presentation Now Available for On-Demand Viewing
More news
Sector news : Biotechnology & Medical Research - NEC
05/22 SYNAGEVA BIOPHARMA : SHAREHOLDER ALERT: Brodsky & Smith, LLC Announces Investiga..
05/22 BLUEBIRD BIO : Announces Participation at the Jefferies 2015 Global Healthcare C..
05/21 ABBVIE : specifies breakdown of $21 billion Pharmacyclics deal
More sector news : Biotechnology & Medical Research - NEC
News from SeekingAlpha
05/22 NEXT WEEK IN BIOTECH : Salix/Valeant PDUFA, ASCO, Brain Tumor Summit
05/19 Immunocellular Therapeutics amends license agreement with Cedars-Sinai
05/12 ImmunoCellular's (IMUC) CEO Andrew Gengos on Q1 2015 Results - Earnings Call ..
05/12 ImmunoCellular Therapeutics net loss improves in Q1
05/11 ImmunoCellular Therapeutics beats by $0.01


Comments 
Advertisement
Chart IMMUNOCELLULAR THERAPEUTIC
Duration : Period :
ImmunoCellular Therapeutic Technical Analysis Chart | IMUC | US4525361055 | 4-Traders
Full-screen chart
Income Statement Evolution
More Financials
EPS Revisions
More Estimates Revisions